A comparative study for efficacy and safety of insertion of ESM UBT(for prevention of PPH) with IM oxytocin 10 IU versuss only IM oxytocin 10 I
Phase 2
- Conditions
- Health Condition 1: O72- Postpartum hemorrhage
- Registration Number
- CTRI/2023/09/057173
- Lead Sponsor
- Dr D SANTHOSHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Delivering viable babies with high-risk pregnancies who are prone to atonic PPH
Grand multipara
Hydramnios
Pregnancy-induced hypertension
Eclampsia
Gestational Diabetes mellitus
Prolonged labour
Abruption
Deranged coagulation profile
Fibroids
Anemia
Twin pregnancy
Exclusion Criteria
Patient with traumatic PPH
Adherent or retained placenta
Uterine rupture
Anomalous uterus
Suspected chorioamnionitis
Purulent infections in cervix, vagina or uterus.
Known advanced cervical cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the blood loss in women in which Dr Burkes UBTwith I.M oxytocin was used to those in whom only I.M oxytocin is used. <br/ ><br>Timepoint: Measuring Blood loss immediately after inserting UBT post delivery & 48hrs after delivery <br/ ><br>
- Secondary Outcome Measures
Name Time Method To assess the safety & efficacy of UBT <br/ ><br>To study the adverse effects of using UBT <br/ ><br>To assess the need for surgical intervention <br/ ><br>To assess the need for uterotonic drugs <br/ ><br>Timepoint: 18months